CDK4/6 inhibitor ribociclib induces cardiotoxicity through impaired E2F1-regulated spliceosome assembly

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of cancer treatment-related cardiovascular toxicity Research and New Technology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

ESC 365 is supported by

ESC 365 is supported by